Syndax Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.12.21	Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab (PR Newswire)
15.11.21	Syndax Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Business Update (PR Newswire)
14.11.21	Ausblick: Syndax Pharmaceuticals präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
08.11.21	Syndax to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 15, 2021 (PR Newswire)
04.11.21	Syndax Pharmaceuticals to Present Updated Data from SNDX-5613 and Axatilimab Clinical Programs During Oral Sessions at 63rd ASH Annual Meeting (PR Newswire)
27.09.21	Syndax Partners With Incyte To Develop, Commercialize Axatilimab - Quick Facts (RTTNews)
27.09.21	Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases (PR Newswire)
15.09.21	Syndax Appoints Martin H. Huber, M.D., to its Board of Directors (PR Newswire)
02.09.21	Syndax Announces Participation at Three Upcoming Investor Conferences (PR Newswire)
09.08.21	Syndax Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Business Update (PR Newswire)
02.08.21	Syndax to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021 (PR Newswire)
28.06.21	Syndax's SNDX-5613 Gets FDA Fast Track Designation To Treat Relapsed/Refractory Acute Leukemias (RTTNews)
28.06.21	SNDX-5613 Granted FDA Fast Track Designation for the Treatment of Relapsed/Refractory Acute Leukemias (PR Newswire)
01.06.21	Analysten sehen für Syndax Pharmaceuticals-Aktie Luft nach oben (finanzen.net)
06.03.21	Ausblick: Syndax Pharmaceuticals stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
31.12.20	Syndax Pharmaceuticals-Aktie: Was Analysten im Dezember vom Papier halten (finanzen.net)
01.11.20	Ausblick: Syndax Pharmaceuticals legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
05.08.20	Ausblick: Syndax Pharmaceuticals informiert über die jüngsten Quartalsergebnisse (finanzen.net)
31.05.20	Analysten sehen für Syndax Pharmaceuticals-Aktie Luft nach oben (finanzen.net)
22.05.20	Stock Alert: Synadax Down 18% (RTTNews)
07.05.20	Ausblick: Syndax Pharmaceuticals stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
29.04.20	Do You Have These Stocks In Your Portfolio? (SNDX, ERYP, IMRA...) (RTTNews)
29.04.20	BPMC's VOYAGER Fails, CLSD's NDA Resubmission Faces Delay, SNDX Hits New High (RTTNews)
31.03.20	Syndax Pharmaceuticals-Aktie: Was Analysten im März vom Papier halten (finanzen.net)
06.03.20	Will 2020 Be An Exciting And Transformative Year For Syndax Pharma (SNDX)? (RTTNews)
02.03.20	Ausblick: Syndax Pharmaceuticals zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
10.10.19	Top 5 Losers In Healthcare Sector (NXTC, SNDX, COCP…) (RTTNews)
05.08.19	Ausblick: Syndax Pharmaceuticals zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
28.06.19	Biopulse: 5 Stocks Under $10 Worth Watching (RTTNews)
04.05.19	Ausblick: Syndax Pharmaceuticals mit Zahlen zum abgelaufenen Quartal (finanzen.net)
28.03.19	6 Top Gainers In Healthcare Sector (IMAC, SNDX, WCG...) (RTTNews)
05.03.19	Ausblick: Syndax Pharmaceuticals zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
03.11.18	Ausblick: Syndax Pharmaceuticals mit Zahlen zum abgelaufenen Quartal (finanzen.net)
25.09.18	FDA Nod For VSTM, ANAB Breathes Easy, GEMP Trims Workforce By 33% (RTTNews)
22.09.18	Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) (RTTNews)
15.09.18	Week Ahead In Pharmaceuticals: 7 Stocks To Watch (CMRX, VRNA, NITE...) (RTTNews)
31.05.18	CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov. (RTTNews)
30.05.18	Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration (PR Newswire)
30.05.18	Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences (PR Newswire)
17.05.18	Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) (PR Newswire)
08.05.18	Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update (PR Newswire)
01.05.18	Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018 (PR Newswire)
25.04.18	Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting (PR Newswire)
16.04.18	MÄRKTE USA/Freundlich - Vorschusslorbeeren für Quartalszahlen (Dow Jones)
13.04.18	Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting (PR Newswire)
15.03.18	DXR Soars On Big Volume, RXII Gets Attention, Busy Q2 Awaits SNDX (RTTNews)
05.03.18	Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update (PR Newswire)
05.03.18	Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences (PR Newswire)
26.02.18	Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Syndax Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten